FOLFOXIRI vs FOLFOX/FOLFIRI + bevacizumab in patients with initially unresectable colorectal liver metastases and right-sided and/or RAS/BRAFV600E mutated primary tumor: phase III CAIRO5 study. Issue 2 (February 2023)

• Record Type: Journal Article
• Authors: Bond, Marinde; Bolhuis, Karen; Van Amerongen, Martin; Dejong, Cornelis; Engelbrecht, Marc; Gerhards, Michael; Van Gulik, Thomas; De Jong, Koert; Kazemier, Geert; Klaase, Joost; Liem, Mike; Van Lienden, Krijn; Molenaar, Quintus; Rijken, Arjen; Verhoef, Cornelis; De Wilt, Johannes; Komurcu, Aysun; Lopez-Yurda, Marta; Punt, Cornelis; Swijnenburg, Rutger-Jan
• Is Part Of: European journal of surgical oncology. Volume 49:Issue 2(2023)
• Page Start: e24
• Publication Date: 2023-02
• Subjects: Oncology -- Periodicals; Cancer -- Surgery -- Periodicals; Medical Oncology -- Periodicals; Neoplasms -- surgery -- Periodicals; Cancer -- Chirurgie -- Périodiques; Cancérologie -- Périodiques; Oncologie; Chirurgie (geneeskunde); Electronic journals; Electronic journals -- Sciences; Electronic journals -- Medicine; Electronic journals; 616.994059005
• DOI: 10.1016/j.ejso.2022.11.116
• Languages: English
• ISSNs: 0748-7983